FDA.reportPublic FDA data

Application 211031

Type
ANDA
Sponsor
BRECKENRIDGE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001EXEMESTANEEXEMESTANETABLET;ORAL25MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
51991-005ExemestaneExemestaneBreckenridge Pharmaceutical, Inc.ANDACurrent
51991-005ExemestaneExemestaneBreckenridge Pharmaceutical, Inc.ANDACurrent
51991-005ExemestaneExemestaneBreckenridge Pharmaceutical, Inc.ANDACurrent
51991-005ExemestaneExemestaneBreckenridge Pharmaceutical, Inc.ANDACurrent
51991-005ExemestaneExemestaneBreckenridge Pharmaceutical, Inc.ANDACurrent
51991-005ExemestaneExemestaneBreckenridge Pharmaceutical, Inc.ANDACurrent
51991-005ExemestaneExemestaneBreckenridge Pharmaceutical, Inc.ANDACurrent
51991-005ExemestaneExemestaneBreckenridge Pharmaceutical, Inc.ANDACurrent
63629-2056ExemestaneExemestaneBryant Ranch PrepackANDACurrent
63629-2056ExemestaneExemestaneBryant Ranch PrepackANDACurrent
63629-2056ExemestaneExemestaneBryant Ranch PrepackANDACurrent